Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program
- PMID: 19455106
- DOI: 10.1038/ajg.2009.191
Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program
Erratum in
- Am J Gastroenterol. 2009 Jul;104(7):1894. Lim, Joseph [corrected to Lim, Joseph K]
Abstract
Cirrhosis represents the end stage of any chronic liver disease. Hepatitis C and alcohol are currently the main causes of cirrhosis in the United States. Although initially cirrhosis is compensated, it eventually becomes decompensated, as defined by the presence of ascites, variceal hemorrhage, encephalopathy, and/or jaundice. These management recommendations are divided according to the status, compensated or decompensated, of the cirrhotic patient, with a separate section for the screening, diagnosis, and management of hepatocellular carcinoma (HCC), as this applies to patients with both compensated and decompensated cirrhosis. In the compensated patient, the main objective is to prevent variceal hemorrhage and any practice that could lead to decompensation. In the decompensated patient, acute variceal hemorrhage and spontaneous bacterial peritonitis are severe complications that require hospitalization. Hepatorenal syndrome is also a severe complication of cirrhosis but one that usually occurs in patients who are already in the hospital and, as it represents an extreme of the hemodynamic alterations that lead to ascites formation, it is placed under treatment of ascites. Recent advances in the pathophysiology of the complications of cirrhosis have allowed for a more rational management of cirrhosis and also for the stratification of patients into different risk groups that require different management. These recommendations are based on evidence in the literature, mainly from randomized clinical trials and meta-analyses of these trials. When few or no data exist from well-designed prospective trials, emphasis is given to results from large series and consensus conferences with involvement of recognized experts. A rational management of cirrhosis will result in improvements in quality of life, treatment adherence, and, ultimately, in outcomes.
Comment in
-
A confusing relationship between Child-Turcotte-Pugh class A and compensated cirrhosis.Am J Gastroenterol. 2010 Feb;105(2):470-2; author reply 472. doi: 10.1038/ajg.2009.626. Am J Gastroenterol. 2010. PMID: 20139882 No abstract available.
Similar articles
-
Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.Am J Gastroenterol. 2009 May;104(5):1147-58. doi: 10.1038/ajg.2009.31. Epub 2009 Apr 7. Am J Gastroenterol. 2009. PMID: 19352340
-
An assessment of the management of acute bleeding varices: a multicenter prospective member-based study.Am J Gastroenterol. 2003 Nov;98(11):2424-34. doi: 10.1111/j.1572-0241.2003.t01-1-07705.x. Am J Gastroenterol. 2003. PMID: 14638344
-
Natural history of compensated viral B and D cirrhosis.Rom J Gastroenterol. 2005 Dec;14(4):329-35. Rom J Gastroenterol. 2005. PMID: 16400347
-
Portal hypertension.Curr Opin Gastroenterol. 2006 May;22(3):254-62. doi: 10.1097/01.mog.0000218962.93806.9a. Curr Opin Gastroenterol. 2006. PMID: 16550040 Review.
-
Advances in the treatment of hepatitis C.Adv Intern Med. 2000;45:65-105. Adv Intern Med. 2000. PMID: 10635046 Review.
Cited by
-
Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update.Gastroenterol Res Pract. 2018 Jun 7;2018:4202091. doi: 10.1155/2018/4202091. eCollection 2018. Gastroenterol Res Pract. 2018. PMID: 29977287 Free PMC article. Review.
-
Prognostic impact of preoperative the branched-chain amino acid to the tyrosine ratio in hepatocellular carcinoma patients after initial hepatectomy.J Gastrointest Surg. 2011 Aug;15(8):1433-9. doi: 10.1007/s11605-011-1566-y. Epub 2011 May 24. J Gastrointest Surg. 2011. PMID: 21607795
-
Clostridium difficile infection in patients with liver disease: a review.Eur J Clin Microbiol Infect Dis. 2015 Dec;34(12):2313-24. doi: 10.1007/s10096-015-2501-z. Epub 2015 Oct 6. Eur J Clin Microbiol Infect Dis. 2015. PMID: 26440041 Review.
-
The Effect of the Gelatinous Lactulose for Postoperative Bowel Movement in the Patients Undergoing Cesarean Section.Int Sch Res Notices. 2014 Oct 29;2014:752862. doi: 10.1155/2014/752862. eCollection 2014. Int Sch Res Notices. 2014. PMID: 27433530 Free PMC article.
-
Repurposing of approved cardiovascular drugs.J Transl Med. 2016 Sep 20;14:269. doi: 10.1186/s12967-016-1031-5. J Transl Med. 2016. PMID: 27646033 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
